Diabetes

In the most recent of the Health Innovators video series, pharmaphorum’s founder, Dr Paul Tunnah, chats with the

Health Innovators: Senseonics’ Francine Kaufman

https://pharmaphorum.com/digital/health-innovators-senseonics-francine-kaufman/

Brexit/ Diabetes/ News/ News/ R&D

Novo Nordisk CEO reassures UK patients over Brexit insulin supplies

Richard Staines Brexit, Diabetes, Novo Nordisk, R&D 0 Comment

Novo Nordisk has doubled its insulin stockpile in the UK, amid patients’ fears that a no-deal Brexit could

Novo Nordisk CEO reassures UK patients over Brexit insulin supplies

https://pharmaphorum.com/news/novo-nordisk-doubles-uk-insulin-stockpile-in-case-of-no-deal-brexit/

AstraZeneca/ Diabetes/ Diabetes/ News/ News/ R&D/ UK & Europe

AstraZeneca improves diabetes pen to maintain its market share

Piotr Wnuk AstraZeneca, Bydureon, Diabetes, GLP-1 0 Comment

The European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug

AstraZeneca improves diabetes pen to maintain its market share

https://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/

Diabetes/ Diabetes/ News/ News/ Patients

FDA warns of genital gangrene risk with diabetes drug class

Piotr Wnuk Diabetes, FDA warning, SGLT2 inhibitors 0 Comment

The US regulator released an official risk warning of a rare genital infection identified in 12 patients, including

FDA warns of genital gangrene risk with diabetes drug class

https://pharmaphorum.com/news/risk-sglt2-inhibitors-fda-warns/

Diabetes/ News/ News/ R&D/ Top stories

Type 2 diabetes research: fewer side effects from modified medication

Joy Persaud Diabetes, drug side effects, Type 2 diabetes 0 Comment

Scientists have made progress in the quest to find medication for Type 2 diabetes that causes fewer side

Type 2 diabetes research: fewer side effects from modified medication

https://pharmaphorum.com/news/diabetes-research-modified-medication/

Diabetes/ News/ News/ News/ Novo Nordisk/ Patients/ R&D/ Top pharmaceutical companies/ Top stories

Real-world diabetes study CONFIRMs positive comparative efficacy for Novo’s Tresiba

Piotr Wnuk Diabetes, Novo Nordisk, Sanofi, Toujeo, Tresiba 0 Comment

Novo Nordisk presented the latest results for its diabetes injectable Tresiba last weekend. These demonstrated significantly better control

Real-world diabetes study CONFIRMs positive comparative efficacy for Novo’s Tresiba

https://pharmaphorum.com/news/tresiba-improved-sugar-control-decreased-hypos/

Diabetes/ Diabetes/ News/ News/ News/ Novo Nordisk/ Patients/ R&D/ Top pharmaceutical companies/ Top stories

Novo’s diabetes pill beats injections in head-to-head trials

Piotr Wnuk Diabetes, diabetes care, GLP-1, Insuline, Januvia, Novo Nordisk, semaglutide, Sitagliptin, Type 2 diabetes, Victoza 0 Comment

Novo Nordisk is making the case for its diabetes pill, which it hopes will allow it to fight

Novo’s diabetes pill beats injections in head-to-head trials

https://pharmaphorum.com/news/novo-nordisks-success-with-oral-diabetes-drug/

Diabetes/ Diabetes/ Healthcare/ News/ News/ Patients

J&J seals $2.1bn deal on sale of major diabetes devices firm

Joy Persaud blood glucose monitor, Diabetes, Glucose, J&J, Johnson and Johnson, Platinum Equity 0 Comment

As part of its ongoing divestment program, a deal worth $2.1 billion has been struck between Johnson &

J&J seals $2.1bn deal on sale of major diabetes devices firm

https://pharmaphorum.com/news/jj-deal-glucose-monitoring-system/

Diabetes/ Market Access/ News/ News

Novo Nordisk undeterred after losing out on Ablynx takeover

Andrew McConaghie Ablynx, Diabetes, Novo Nordisk, Ozempic 0 Comment

After losing out to Sanofi in its pursuit of Belgian biotech Ablynx earlier this week, Novo Nordisk has put a brave face on the disappointment.

Novo Nordisk undeterred after losing out on Ablynx takeover

https://pharmaphorum.com/news/novo-nordisk-undeterred-losing-ablynx-takeover/

1 2

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Diabetes

Login